CDC42 and cancer: For instance, hyper activation of receptor tyrosine kinases (RTKs, two-third of known TKs)69 has been shown to be implicated in cancer even in the absence of extracellular activating ligands via overexpression of RTKs70, activating mutations71 or autocrine stimulation58,72.